SEARCH

SEARCH BY CITATION

References

  • 1
    Malling H-J. EAACI/PTA symposium reviews. Immunotherapy as an effective tool in allergy treatment. Allergy 1998;53:461472.
  • 2
    Stewart EG, Lockey RF. Systemic reactions from allergen immunotherapy. J Allergy Clin Immunol 1992;90:567578.
  • 3
    Wekkeli M, Rosenkranz A, Hippamann G, et al. [Systemic side-effects in immunotherapy of allergic diseases – a comparative study]. Wien Klin Wochenschr 1989;101:639652.
  • 4
    Haugaard L, Dahl R, Jacobsen L. A controlled dose-response study of immunotherapy with standardized, partially purified extract of house dust mite: clinical efficacy and side-effects. J Allergy Clin Immunol 1993;91:709722.
  • 5
    Hejjaoui A, Dhivert H, Michel FB, Bousquet J. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. IV. Systemic reactions according to the immunotherapy schedule. J Allergy Clin Immunol 1990;85:473479.
  • 6
    Hejjaoui A, Ferrando R, Dhivert H, et al. Systemic reactions occurring during immunotherapy with standardized pollen extracts. J Allergy Clin Immunol 1992;89:925933.
  • 7
    Tabar AI, Garcia BE, Rodriguez A, et al. A prospective safety-monitoring study of immunotherapy with biologically standardized extracts. Allergy 1993;48:450453.
  • 8
    Østergaard PA, Kaad PH, Kristensen T. A prospective study on the safety of immunotherapy in children with severe asthma. Allergy 1986;41:588593.
  • 9
    Ragusa FV, Passalacqua G, Gambardella R, et al. Nonfatal systemic reactions to subcutaneous immunotherapy: a 10-year experience. J Investig Allergol Clin Immunol 1997;7:151154.
  • 10
    Möller C, Dreborg S. Cross-reactivity between deciduous trees during immunotherapy. I. In vivo results. Clin Allergy 1986;16:135143.
  • 11
    Varney VA, Gaga M, Frew AJ, et al. Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs [see comments]. BMJ 1991;302:265269.
  • 12
    Walker SM, Varney VA, Gaga M, et al. Grass-pollen immunotherapy: efficacy and safety during a 4-year follow-up study. Allergy 1995;50:405413.
  • 13
    Østerballe O. Side-effects during immunotherapy with purified grass-pollen extracts. Allergy 1982;37:553562.
  • 14
    Bentley AM, Jacobson MR, Cumberworth V, et al. Immunohistology of the nasal mucosa in seasonal allergic rhinitis: increases in activated eosinophils and epithelial mast cells. J Allergy Clin Immunol 1992;89:877883.
  • 15
    Carlson M, Håkansson L, Kampe M, et al. Degranulation of eosinophils from pollen-atopic patients with asthma is increased during pollen season. J Allergy Clin Immunol 1992;89:131139.
  • 16
    Carlson M, Håkansson L, Peterson C, et al. Secretion of granule proteins from eosinophils and neutrophils is increased in asthma. J Allergy Clin Immunol 1991;87:2733.
  • 17
    Marone G, Spadaro G, Patella V, Genovese A. The clinical relevance of basophil releasability. J Allergy Clin Immunol 1994;94:12931302.
  • 18
    Naclerio RM, Baroody FM, Kagey-Sobotka A, Lichtenstein LM. Basophils and eosinophils in allergic rhinitis. J Allergy Clin Immunol 1994;94:13031309.
  • 19
    Schroeder JT, Kagey-Sobotka A, Lichtenstein LM. The role of the basophil in allergic inflammation. Allergy 1995;50:463472.
  • 20
    Winther L, Moseholm L, Mosbech H, Malling H-J. Allergen-specific immunotherapy in birch- and grass-pollen-allergic rhinitis. I. Efficacy estimated by a model reducing the bias of annual differences in pollen counts. Allergy 2000;55:818826.
  • 21
    Malling H-J, Weeke B. EAACI position paper. Immunotherapy. Allergy 1993;48 Suppl 14:945.
  • 22
    Möller C, Björkstén B, Nilsson G, Dreborg S. The precision of the conjunctival provocation test. Allergy 1984;39:3741.
  • 23
    Druce HM, Schumacher MJ. Nasal provocation challenge. The Committee on Upper Airway Allergy. J Allergy Clin Immunol 1990;86:261264.
  • 24
    Dreborg S, Frew A. EAACI position paper. Allergen standardization and skin tests. Allergy 1993;48 Suppl 14:4982.
  • 25
    Poulsen LK, Liisberg C, Bindslev-Jensen C, Malling H-J. Precise area determination of skin-prick tests: validation of a scanning device and software for a personal computer. Clin Exp Allergy 1993;23:6168.
  • 26
    Nolte H, Schiøtz O, Skov PS. A new glass microfibre-based histamine analysis for allergy testing in children: results compared with conventional leukocyte histamine release assay, skin prick test, bronchial provocation test and RAST. Allergy 1987;42:366373.
  • 27
    Reimert CM, Poulsen LK, Bindslev-Jensen C, et al. Measurement of eosinophil cationic protein (ECP) and eosinophil protein X/eosinophil derived neurotoxin (EPX/EDN). Time and temperature dependent spontaneous release in vitro demands standardized sample processing. J Immunol Methods 1993;166:183190.
  • 28
    Altman DG. Practical statistics for medical research. New York: Chapman & Hall, 1992.
  • 29
    Mosbech H, Dirksen A, Dreborg S, et al. Hyposensitization in asthmatics with mPEG-modified and unmodified house dust mite extract. IV. Occurrence and prediction of side-effects. Allergy 1990;45:142150.
  • 30
    Bousquet J, Hejjaoui A, Dhivert H, et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. Systemic reactions during the rush protocol in patients suffering from asthma. J Allergy Clin Immunol 1989;83:797802.
  • 31
    Tinkelman DG, Cole WQ, Tunno J. Immunotherapy: a one-year prospective study to evaluate risk factors of systemic reactions. J Allergy Clin Immunol 1995;95:814.
  • 32
    Nelson BL, Dupont LA, Reid MJ. Prospective survey of local and systemic reactions to immunotherapy with pollen extracts. Ann Allergy 1986;56:331334.
  • 33
    Nielsen L, Johnsen CR, Mosbech H, et al. Antihistamine premedication in specific cluster immunotherapy: a double-blind, placebo-controlled study. J Allergy Clin Immunol 1996;97:12071213.
  • 34
    Zenner HP, Baumgarten C, Rasp G, et al. Short-term immunotherapy: a prospective, randomized, double-blind, placebo-controlled multicenter study of molecular standardized grass and rye allergens in patients with grass-pollen-induced allergic rhinitis. J Allergy Clin Immunol 1997;100:2329.
  • 35
    Bousquet J, Hejjaoui A, Soussana M, Michel FB. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. IV. Comparison of the safety and efficacy of two dosages of a high-molecular-weight allergoid. J Allergy Clin Immunol 1990;85:490497.